TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PolyPeptide Laboratories (Sweden) AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
765,962
|
716,186
|
602,295 |
| Financial expenses |
9,486
|
15,768
|
2,458 |
| Earnings before taxes |
209,917
|
130,232
|
200,225 |
| EBITDA |
237,946
|
173,814
|
186,164 |
| Total assets |
1,715,957
|
1,337,538
|
1,013,741 |
| Current assets |
1,106,230
|
890,108
|
598,277 |
| Current liabilities |
391,466
|
280,221
|
210,352 |
| Equity capital |
570,148
|
751,874
|
699,293 |
| - share capital |
7,469
|
7,724
|
7,685 |
| Employees (average) |
350
|
312
|
325 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.2%
|
56.2%
|
69.0% |
| Turnover per employee |
2,188
|
2,295
|
1,853 |
| Profit as a percentage of turnover |
27.4%
|
18.2%
|
33.2% |
| Return on assets (ROA) |
12.8%
|
10.9%
|
20.0% |
| Current ratio |
282.6%
|
317.6%
|
284.4% |
| Return on equity (ROE) |
36.8%
|
17.3%
|
28.6% |
| Change turnover |
73,465
|
110,789
|
-50,696 |
| Change turnover % |
11%
|
18%
|
-8% |
| Chg. No. of employees |
38
|
-13
|
28 |
| Chg. No. of employees % |
12%
|
-4%
|
9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.